These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2312176)

  • 1. Co-trimoxazole for visceral leishmaniasis.
    Rodriguez-Cuartero A; Pérez-Blanco FJ; López-Fernández A
    Infection; 1990; 18(1):40. PubMed ID: 2312176
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-trimoxazole for leishmaniasis-or metronidazole?
    Masramon J; Aubia J; Lloveras J; Llorach I; Llorach M
    Lancet; 1981 Mar; 1(8221):669. PubMed ID: 6110896
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-trimoxazole for systemic leishmaniasis.
    Murphy KJ; Bong AC
    Lancet; 1981 Feb; 1(8215):323-4. PubMed ID: 6109955
    [No Abstract]   [Full Text] [Related]  

  • 4. A combination of sulphadiazine, trimethoprim and metronidazole or tinidazole in kala-azar.
    Bano P; Shahab SM
    J Assoc Physicians India; 1994 Jul; 42(7):535-6. PubMed ID: 7868522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-trimoxazole for kala-azar.
    Guardia J
    Lancet; 1981 Feb; 1(8218):501-2. PubMed ID: 6110121
    [No Abstract]   [Full Text] [Related]  

  • 6. Metronidazole therapy for visceral leishmaniasis.
    Laguna del Estal P; Moya MS; Martín T; Lucero MJ; Salgado R
    Clin Infect Dis; 1994 Dec; 19(6):1161-2. PubMed ID: 7888556
    [No Abstract]   [Full Text] [Related]  

  • 7. Visceral leishmaniasis treated with rifampicin and co-trimoxazole.
    Chatterjee S; Chatterjee R
    J Indian Med Assoc; 1994 Sep; 92(9):307. PubMed ID: 7814908
    [No Abstract]   [Full Text] [Related]  

  • 8. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
    Thakur CP; Sinha PK
    J Trop Med Hyg; 1989 Dec; 92(6):383-5. PubMed ID: 2607570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kala-azar. Presentation of 7 cases and review of the literature].
    García de Miguel MJ; López-Herce Cid J; Ramirez Balza O; Vidal López ML; García Hortelano J
    An Esp Pediatr; 1984 Oct; 21(6):587-92. PubMed ID: 6395745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis and other severe infections in an adult patient with p47-phox-deficient chronic granulomatous disease.
    Asensi V; Tricas L; Meana A; Roos D; Carton JA; Maradona JA; Fresno MF; Valle E; Fierer J; Arribas JM
    Infection; 2000; 28(3):171-4. PubMed ID: 10879644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough in the management of visceral leishmaniasis.
    Thakur BB
    J Assoc Physicians India; 2003 Jul; 51():649-51. PubMed ID: 14621030
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment options for visceral leishmaniasis.
    den Boer M; Davidson RN
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):187-97. PubMed ID: 16597201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
    Murray HW
    Future Microbiol; 2010 Sep; 5(9):1301-3. PubMed ID: 20860475
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis?
    Nandy A; Addy M; Maji AK; Guha SK
    Ann Trop Med Parasitol; 2004 Sep; 98(6):651-4. PubMed ID: 15324473
    [No Abstract]   [Full Text] [Related]  

  • 15. Engima of therapeutic failure in visceral leishmaniasis.
    Arya SC
    J Assoc Physicians India; 1993 Mar; 41(3):155-8. PubMed ID: 8226600
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole in transrectal prostatic biopsy.
    Fong IW; Struthers N; Honey RJ; Simbul M; Boisseau DA
    J Urol; 1991 Sep; 146(3):794-7. PubMed ID: 1908529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
    Ghosh S; Kar N; Bera T
    Int J Biol Macromol; 2016 Dec; 93(Pt A):961-970. PubMed ID: 27645930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
    Thakur CP; Dedet JP; Narain S; Pratlong F
    Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous involvement in a rare case of adult visceral leishmaniasis acquired in Israel.
    Ben-Ami R; Schnur LF; Golan Y; Jaffe CL; Mardi T; Zeltser D
    J Infect; 2002 Apr; 44(3):181-4. PubMed ID: 12099746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
    Pal S; Ravindran R; Ali N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.